COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices

作者全名："Wang, Zijun; Liu, Hui; Li, Yang; Luo, Xufei; Yang, Nan; Lv, Meng; Zhou, Qi; Li, Qinyuan; Wang, Ling; Zhao, Junxian; Liu, Yunlan; Su, Renfeng; Wu, Shouyuan; Liu, Xiao; Zhao, Siya; Shi, Qianling; Estill, Janne; Liu, Xingrong; Zhang, Wenhong; Chen, Yaolong"

作者地址："[Wang, Zijun; Yang, Nan; Zhou, Qi; Chen, Yaolong] Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou, Peoples R China; [Wang, Zijun; Chen, Yaolong] Lanzhou Univ, Inst Hlth Data Sci, Lanzhou, Peoples R China; [Liu, Hui; Luo, Xufei; Wang, Ling; Zhao, Junxian; Liu, Yunlan; Su, Renfeng; Wu, Shouyuan; Liu, Xiao; Zhao, Siya; Liu, Xingrong; Chen, Yaolong] Lanzhou Univ, Sch Publ Hlth, Lanzhou, Peoples R China; [Li, Yang; Zhang, Wenhong] Fudan Univ, Huashan Hosp, Natl Med Ctr Infect Dis, Dept Infect Dis,Shanghai Key Lab Infect Dis & Bio, Shanghai, Peoples R China; [Lv, Meng] Chongqing Med Univ, Childrens Hosp, Dept Nephrol, Chongqing, Peoples R China; [Li, Qinyuan] Chongqing Med Univ, Childrens Hosp, Dept Resp Med, Chongqing, Peoples R China; [Shi, Qianling] Lanzhou Univ, Sch Clin Med 1, Lanzhou, Peoples R China; [Estill, Janne] Univ Geneva, Inst Global Hlth, Geneva, Switzerland; [Estill, Janne] Univ Bern, Inst Math Stat & Actuarial Sci, Bern, Switzerland; [Zhang, Wenhong] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China; [Zhang, Wenhong] Fudan Univ, Key Lab Med Mol Virol MOE MOH, Shanghai Med Coll, Shanghai, Peoples R China; [Chen, Yaolong] WHO Collaborating Ctr Guideline Implementat & Kno, Lanzhou, Peoples R China; [Chen, Yaolong] Guideline Int Network Asia, Lanzhou, Peoples R China; [Chen, Yaolong] Chinese GRADE Ctr, Lanzhou, Peoples R China"

通信作者："Chen, YL (通讯作者)，Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou, Peoples R China.; Chen, YL (通讯作者)，Lanzhou Univ, Inst Hlth Data Sci, Lanzhou, Peoples R China.; Liu, XR; Chen, YL (通讯作者)，Lanzhou Univ, Sch Publ Hlth, Lanzhou, Peoples R China.; Zhang, WH (通讯作者)，Fudan Univ, Huashan Hosp, Natl Med Ctr Infect Dis, Dept Infect Dis,Shanghai Key Lab Infect Dis & Bio, Shanghai, Peoples R China.; Zhang, WH (通讯作者)，Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China.; Zhang, WH (通讯作者)，Fudan Univ, Key Lab Med Mol Virol MOE MOH, Shanghai Med Coll, Shanghai, Peoples R China.; Chen, YL (通讯作者)，WHO Collaborating Ctr Guideline Implementat & Kno, Lanzhou, Peoples R China.; Chen, YL (通讯作者)，Guideline Int Network Asia, Lanzhou, Peoples R China.; Chen, YL (通讯作者)，Chinese GRADE Ctr, Lanzhou, Peoples R China."

来源：JOURNAL OF CLINICAL EPIDEMIOLOGY

ESI学科分类：SOCIAL SCIENCES, GENERAL

WOS号：WOS:000786657100013

JCR分区：Q1

影响因子：7.2

年份：2022

卷号：144

期号：　

开始页：163

结束页：172

文献类型：Article

关键词：COVID-19; Vaccine; Guideline; Methodology; Transparency; Conflict of interest

摘要："Objective: To describe the current status of COVID-19 vaccine guidelines. Study Design and Setting: We searched databases, Google and guideline platforms to retrieve COVID-19 vaccine guidelines published between January 1, 2020 and July 8, 2021. We worked in pairs to identify the eligible guidelines and extract data of whether the methodology, funding, and conflict of interests were assessed/reported, and so on. Results were presented descriptively. Results: A total of 106 COVID-19 vaccine guidelines were included. In the first half of 2021, on average 15 guidelines were published every month. Fifty (47.2%) guidelines addressed the vaccination of people with specific medical conditions, and 18 (17.0%) guidelines focused on adverse effects after vaccination. Only 28 (26.4%) guidelines reported the methodology they used. Four (3.8%) of guidelines assessed both the quality of evidence and strength of recommendations; 42 (39.6%) and 65 (61.3%) guidelines reported their funding sources and conflict of interest, respectively. Most guidelines were published in English (n = 92, 86.8%). Conclusion: A high number of guidelines on COVID-19 vaccines have been published in the recent months, but most of them lack clear and transparent reporting of methodology, funding, and conflicts of interest. Rigorous methodological and reporting quality evaluation of these guidelines is needed. (C) 2021 The Author(s). Published by Elsevier Inc."

基金机构：　

基金资助正文：